WHAT WE RESEARCH
EXAMPLES OF OUR WORK
We have a broad range of experience with our research projects involving a multitude of conditions and clients. These experiences have fine-tuned our open and neutral perception necessary for the design of an appropriate research strategy in your specific sector.
Please feel free to order some samples of our work
ETHNOGRAPHIC RHEUMATOID ARTHRITIS PATIENT STUDY
PHASE 1IN-DEPTH-INTERVIEWS / RA-PATIENTS OBJECTIVE: PATIENT EXPERIENCE AND EVALUATION BY PATIENTS
|
PHASE 2VIDEO DIARY + IN-DEPTH-INTERVIEWS / RA-PATIENTS OBJECTIVE:
|
FACE TO FACE INTERVIEWS VIROLOGY
STATUS-QUO-ANALYSIS INFECTIOUS DISEASE / SPECIALISTS / VIROLOGISTS
IN-DEPTH-INTERVIEWS
OBJECTIVE:
- By means of a study conducted amongst infectious disease specialists / virologists (specialist centres), XY Corporation wishes to assess both the current image of XY as well as customer satisfaction within that target group
- Gathering suggestions for measures (e.g., services / communication channels) to foster even closer cooperation as well as for potential marketing activities
- 40 face-to-face interviews conducted with infectious disease specialists / virologists
PAIN MEDICATION MULTIPHASE STUDY
LAUNCH-POSITIONING
PHASE 1IN-DEPTH-INTERVIEWS OBJECTIVE: PAIN SPECIALISTS
OBJECTIVE: PATIENTS
|
PHASE 2IN-DEPTH-INTERVIEWS + MINI GROUPS OBJECTIVE: MESSAGE FLOW AND POSITIONING
|
PHASE 3IN-DEPTH-INTERVIEWS / GPs OBJECTIVE: FINE TUNING OF MESSAGE
|
POST-LAUNCH
PHASE 4IN-DEPTH-INTERVIEWS + MINI GROUPS / GPS OBJECTIVE: INCREASING SALES POSTLAUNCH & IDENTIFYING POTENTIAL PROBLEM AREAS
|
PHASE 5IN-DEPTH-INTERVIEWS + TRIADS / DYADS USERS & NON-USERS OBJECTIVE: MESSAGE TESTING AND PATIENT PROFILE DEVELOPMENT
|
EXAMPLES OF OUR WORK
We have a broad range of experience with our research projects involving a multitude of conditions and clients. These experiences have fine-tuned our open and neutral perception necessary for the design of an appropriate research strategy in your specific sector.
Please feel free to order some samples of our work
ETHNOGRAPHIC RHEUMATOID ARTHRITIS PATIENT STUDY
PHASE 1
IN-DEPTH-INTERVIEWS / RA-PATIENTS
OBJECTIVE: PATIENT EXPERIENCE AND EVALUATION BY PATIENTS
- Familiarity with and usage of various treatments for RA pain management
- Emotional components
- Ideal products and review of the concepts
PHASE 2
VIDEO DIARY + IN-DEPTH-INTERVIEWS / RA-PATIENTS
OBJECTIVE:
- Gaining insight into the everyday lives of patients suffering from rheumatoid arthritis in order to enable the development of suitable product positioning approaches and product messages
FACE TO FACE INTERVIEWS VIROLOGY
STATUS-QUO-ANALYSIS INFECTIOUS DISEASE / SPECIALISTS / VIROLOGISTS
IN-DEPTH-INTERVIEWS
OBJECTIVE:
- By means of a study conducted amongst infectious disease specialists / virologists (specialist centres), XY Corporation wishes to assess both the current image of XY as well as customer satisfaction within that target group
- Gathering suggestions for measures (e.g., services / communication channels) to foster even closer cooperation as well as for potential marketing activities
- 40 face-to-face interviews conducted with infectious disease specialists / virologists
PAIN MEDICATION MULTIPHASE STUDY
LAUNCH-POSITIONING
PHASE 1
IN-DEPTH-INTERVIEWS
PAIN SPECIALISTS & PAIN PATIENTS
OBJECTIVE: PAIN SPECIALISTS
- Perceptions of peripheral neuropathic pain and treatment goals
Patient typology - Understanding the competitive landscape and unmet needs
- Evaluation of the product profile of Product X and evaluation of the brand
- Understanding how the brand Product X could potentially be further developed
OBJECTIVE: PATIENTS
- Perceptions of peripheral neuropathic pain
- Day-to-day life with peripheral neuropathic pain, thoughts on their medication
- Relationships with doctors
- Evaluation of Product X
PHASE 2
IN-DEPTH-INTERVIEWS + MINI GROUPS
PAIN SPECIALISTS
OBJECTIVE: MESSAGE FLOW AND POSITIONING
-
- Perceptions of the therapy area
- Product profile
- Key messages
- Product positioning
- Narrative flow of the key messages
PHASE 3
IN-DEPTH-INTERVIEWS / GPs
OBJECTIVE: FINE TUNING OF MESSAGE
-
-
- FLOW AND POSITIONING
- Treatment goals
- Brief introduction of the product profile
- Gallery exercise – spontaneous reactions to, and recall of the concepts
- In-depth review of each concept, one after the other
- Identification of the best concept / best match with the communication goal
-
POST-LAUNCH
PHASE 4
IN-DEPTH-INTERVIEWS + MINI GROUPS / GPS
OBJECTIVE: INCREASING SALES POSTLAUNCH & IDENTIFYING POTENTIAL PROBLEM AREAS
-
-
- Perceptions of peripheral neuropathic pain and treatment goals
- Perceptions of pharmaceutical products currently used to treat peripheral neuropathic pain
- Respondents’ past experiences with Product X
- Measures to increase the market acceptance of Product X
-
PHASE 5
IN-DEPTH-INTERVIEWS + TRIADS / DYADS USERS & NON-USERS
OBJECTIVE: MESSAGE TESTING AND PATIENT PROFILE DEVELOPMENT
-
-
-
- Current perceptions of available treatments
- Evaluation of the messages
- Exploration, evaluation and refinement of the patient profiles
- Development of the narrative flow
-
-
+1
Happy Clients
+1
Years of team expierence
+1
Contacts to HPCs
+1
Happy Clients
+1
Years of team expierence
+1
Contacts to HPCs
OUR EXPERTISE
We have worked across a wide range of therapy areas and sectors, i.e.:
Breast
Bladder
Colorectal
NSCLC/SCLC
Ovarian
Prostate
Pancreatic
Thyroid cancer
Uterus Myoma
Renal
Carbapenem-resistant gram-negative infections
Hepatitis
HIV
Influenza
Ankylosing Spondylitis
Osteoarthritis
Paget ́s Disease
Rheumatoid Arthritis
Systemic lupus erythematosus
ALL
AML
CLL
Lymphoma – FL/NHL
Multiple myeloma
Myelofibrosis
Paroxysmal nocturnal hemoglobinuria (PNH)
Squamous cell carcinoma
Acne
Eczema
Psoriasis
Malignant Melanomas
Systemic Sclerosis
Attention deficit disorder
Alzheimer
Bipolar disorders
Chronic Pain Management
Drug Substitution
Depression
Epilepsy
Fibromyalgia
Migraine
Multiple sclerosis
Parkinsons ́disease
Restless Leg Syndrome
Schizoaffective Disorder
Schizophrenia
Spinal muscular atrophy (SMA)
Erectile Dysfunction
Intermit catheters
Hyperactive bladder
Urinary Incontinence
Atypical hemolytic uremic
syndrome (aHUS)
Cystic fibrosis
CHD
Fabry disease
Gaucher disease
Hereditary angioedema (HAE)
Haemophilia
Myasthenia gravis
Pulmonary arterial hypertension (PAH)
Primary immune deficiency diseases (PIDDs)
Age-Related Macular Degeneration (AMD)
Macular holes
Uveitis
Vitreomacular adhesion (VMA)
Breast
Bladder
Colorectal
NSCLC/SCLC
Ovarian
Prostate
Pancreatic
Thyroid cancer
Uterus Myoma
Renal
Carbapenem-resistant gram-negative infections
Hepatitis
HIV
Influenza
Ankylosing Spondylitis
Osteoarthritis
Paget ́s Disease
Rheumatoid Arthritis
Systemic lupus erythematosus
Attention deficit disorder
Alzheimer
Bipolar disorders
Chronic Pain Management
Drug Substitution
Depression
Epilepsy
Fibromyalgia
Migraine
Multiple sclerosis
Parkinsons ́disease
Restless Leg Syndrome
Schizoaffective Disorder
Schizophrenia
Spinal muscular atrophy (SMA)
Erectile Dysfunction
Intermit catheters
Hyperactive bladder
Urinary Incontinence
ALL
AML
CLL
Lymphoma – FL/NHL
Multiple myeloma
Myelofibrosis
Paroxysmal nocturnal hemoglobinuria (PNH)
Squamous cell carcinoma
Acne
Eczema
Psoriasis
Malignant Melanomas
Systemic Sclerosis
Atypical hemolytic uremic
syndrome (aHUS)
Cystic fibrosis
CHD
Fabry disease
Gaucher disease
Hereditary angioedema (HAE)
Haemophilia
Myasthenia gravis
Pulmonary arterial hypertension (PAH)
Primary immune deficiency diseases (PIDDs)
Age-Related Macular Degeneration (AMD)
Macular holes
Uveitis
Vitreomacular adhesion (VMA)
HAEMATOLOGY & ONCOLOGY
We have years of experience and expertise in oncology and heamatoncology.
Our expertise spans the entire lifecycle of oncology drugs from early development to commercialisation.
Using our in-depth knowledge of the oncology landscape helps you to develop a distinct brand and to create powerful marketing material.
PRE-LAUNCH STUDY CAR-T
12 IDIs 60 MIN / HEMATOLOGIST & TRANSPLANTERS
IN-DEPTH-INTERVIEWS
OBJECTIVE: IDENTIFYING THE CAR-T STAKEHOLDERS
-
-
-
- Identification of overall awareness of CAR-T therapy across physicians (hematologist & transplanters).
- Identification of different HCP segments for using CAR-T
- Who is open to use CAR-T and what are the drivers/barriers
- Patient typology -What patients will be referred vs. not referred for CAR-T therapy?
- What patients are most appropriate for CAR-T therapy?
- Understanding the competitive landscape
- How choose HCPs one CAR-T over another?
- Evaluation of the product profile of Product X
-
-
HAEMATOLOGY & ONCOLOGY
We have years of experience and expertise in oncology and heamatoncology.
Our expertise spans the entire lifecycle of oncology drugs from early development to commercialisation.
Using our in-depth knowledge of the oncology landscape helps you to develop a distinct brand and to create powerful marketing material.
PRE-LAUNCH STUDY CAR-T
12 IDIs 60 MIN / HEMATOLOGIST & TRANSPLANTERS
IN-DEPTH-INTERVIEWS
OBJECTIVE: IDENTIFYING THE CAR-T STAKEHOLDERS
-
-
-
- Identification of overall awareness of CAR-T therapy across physicians (hematologist & transplanters).
- Identification of different HCP segments for using CAR-T
- Who is open to use CAR-T and what are the drivers/barriers
- Patient typology -What patients will be referred vs. not referred for CAR-T therapy?
- What patients are most appropriate for CAR-T therapy?
- Understanding the competitive landscape
- How choose HCPs one CAR-T over another?
- Evaluation of the product profile of Product X
-
-